Skip to Content
Merck
CN

1445357

USP

Modafinil Related Compound B

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

2-[(Diphenylmethyl)sulfonyl]acetamide, 2-(Benzhydrylsulfonyl)acetamide, Modafinil sulfone

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C15H15NO3S
CAS Number:
Molecular Weight:
289.35
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
9199801
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

pharmaceutical primary standard

API family

modafinil

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

NC(=O)CS(=O)(=O)C(c1ccccc1)c2ccccc2

InChI

1S/C15H15NO3S/c16-14(17)11-20(18,19)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)

InChI key

ZESNOWZYHYRSRY-UHFFFAOYSA-N

Application

Modafinil Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.


Still not finding the right product?

Explore all of our products under Modafinil Related Compound B


flash_point_f

Not applicable

flash_point_c

Not applicable

Storage Class

11 - Combustible Solids



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



High-performance liquid chromatographic determination of modafinil and its two metabolites in human plasma using solid-phase extraction.
Burnat, Pascal, Fabrice Robles, and Bernard Do.
Journal of Chromatography. B, Biomedical Sciences and Applications, 706.2, 295-304 (1998)
Mona Darwish et al.
Clinical therapeutics, 37(2), 325-337 (2014-12-03)
Polypharmacy is common in psychiatry practice and can lead to an increased risk of drug interactions. Armodafinil, a wakefulness-promoting agent, has been studied as adjunctive therapy for the treatment of major depressive episodes associated with bipolar I disorder. Armodafinil and



Global Trade Item Number

SKUGTIN
1445357-20MG04061833852132